Marfin Anthony A, Eidex Rachel S Barwick, Kozarsky Phyllis E, Cetron Martin S
Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, CO 80522, USA.
Infect Dis Clin North Am. 2005 Mar;19(1):151-68, ix. doi: 10.1016/j.idc.2004.11.004.
Appropriate administration of yellow fever or Japanese encephalitis vaccines to travelers requires an assessment of the traveler's risk for infection with these vector-borne flaviviruses during their travels and the presence of risk factors for adverse events following immunization. Japanese encephalitis and yellow fever vaccines have been more frequently associated with serious adverse events following immunization since the early 1980s and the late 1990s, respectively. This article describes the adverse events, the magnitude of their risk, and associated risk factors.
对旅行者合理接种黄热病或日本脑炎疫苗,需要评估旅行者在旅行期间感染这些媒介传播黄病毒的风险,以及免疫接种后出现不良事件的风险因素。自20世纪80年代初和90年代末以来,日本脑炎疫苗和黄热病疫苗分别更频繁地与免疫接种后的严重不良事件相关联。本文描述了这些不良事件、其风险程度以及相关风险因素。